Pages that link to "Q32165734"
Jump to navigation
Jump to search
The following pages link to Alterations of apolipoprotein B metabolism in HIV-infected patients with antiretroviral combination therapy (Q32165734):
Displaying 18 items.
- Sterol regulatory element-binding proteins and reactive oxygen species: potential role in highly-active antiretroviral therapy (HAART)-associated lipodystrophy (Q34460031) (← links)
- Goals and milestones during treatment of HIV-1 infection with antiretroviral therapy: a pathogenesis-based perspective (Q34699524) (← links)
- Evaluation and management of dyslipidemia in patients with HIV infection (Q34743413) (← links)
- HIV protease inhibitors and obesity (Q34792983) (← links)
- Effects of HIV protease inhibitor therapy on lipid metabolism (Q35053466) (← links)
- Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease (Q35104006) (← links)
- Improved triglycerides and insulin sensitivity with 3 months of acipimox in human immunodeficiency virus-infected patients with hypertriglyceridemia (Q35384143) (← links)
- Diagnostic markers based on a computational model of lipoprotein metabolism (Q35834874) (← links)
- A Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated Lipodystrophy (Q35899038) (← links)
- Risk factors for cardiovascular disease in children infected with human immunodeficiency virus-1. (Q37016598) (← links)
- Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy. (Q37086312) (← links)
- Metabolic Abnormalities Associated with the Use of Protease Inhibitors and Non-nucleoside Reverse Transcriptase Inhibitors (Q39670294) (← links)
- Cardiometabolic disease in human immunodeficiency virus-infected children (Q40096020) (← links)
- Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins. (Q40389936) (← links)
- LDL-receptors expression in HIV-infected patients: relations to antiretroviral therapy, hormonal status, and presence of lipodystrophy (Q44004417) (← links)
- Decrease in LDL size in HIV-positive adults before and after lopinavir/ritonavir-containing regimen: an index of atherogenicity? (Q44430812) (← links)
- In treatment-naïve and antiretroviral-treated subjects with HIV, reduced plasma adiponectin is associated with a reduced fractional clearance rate of VLDL, IDL and LDL apolipoprotein B-100. (Q46908306) (← links)
- [Adverse effects of antiretroviral therapy. Aspects of pathogenesis] (Q79183185) (← links)